22nd Century Group, a leader in tobacco harm reduction, has entered into a new cannabis research collaboration with Anandia Laboratories.
As a part of this research collaboration, Vancouver, Canada-based Anandia Laboratories will develop and grow cannabis strains that express highly desirable characteristics and will lead to potential commercialization opportunities. The initial focus of the collaboration will include cannabinoid-free cannabis for the commercial hemp industry and high levels of non-THC cannabinoids, such as CBD, for legal medical marijuana markets.
Dr. Paul Rushton, 22nd Century’s new vice president of plant biotechnology, will have responsibility for the company’s partnership with Anandia Laboratories.